Member Directory

Established in May 2016, The AMR Centre is a key part of the UK’s response to the global threat from Antimicrobial Resistance. Based at Alderley Park, The AMR Centre is a joint private-public initiative to support/accelerate the development of new antibiotics and diagnostics through a fully integrated development capability, offering translational R&D from pre-clinical hits through to clinical proof of concept.

Cambivac® Ltd researches, develops and out-licenses innovative vaccine technologies. We benefit from a close relationship with the University of Cambridge which facilitates our aims of bringing together world class expertise in the fields of traditional virology, modern genomics and molecular vaccine approaches. We adopt a multi-disciplinary approach towards providing novel solutions to current and emerging disease challenges; particularly well suited to zoonotic disease challenges which are of ever increasing importance - given the fact that 75% of emerging human diseases are zoonotic.

Cranleigh Scientific is a family-owned specialist recruitment company, delivering bespoke resource solutions to the scientific sector across UK. We have been carefully building relationships, listening to our customers and delivering high quality personnel since 2001.. . We have a division dedicated to Life Sciences, and fill roles within the following skill areas in :. . •

CROS NT is an international Contract Research Organization (CRO) specialized in clinical data services including Biostatistics methodology, programming and analysis, Clinical Data Management, Medical Writing, Pharmacovigilance and Clinical Technologies (EDC, ePRO, IWRS, CTMS) for Phase I-IV drug development trials as well as medical device studies.. . We work with Sponsors in a supportive and consultative manner. We offer value by centralizing clinical data and providing a window to show the status of all studies. We maximize re-use from previous studies, standardizing data formats, providing a consistent team – all with the objective of enhancing quality and saving up 40% on cost. We provide the flexibility to work “project by project” or through providing dedicated teams [Functional Service Provision (FSP)].

Innovative world leader in manufacture of Robotics with special focus on Synthetic Biology

Custom Pharma Services (CPS) as a strategic business unit of Dr Reddy’s draws on years of knowledge and expertise in pharmaceutical development and manufacturing to provide innovators with customised services and solutions for intermediates, active ingredients and finished dosages. Within a short span, we have become one of the largest pharmaceutical outsourcing players from India and a global partner-of-choice. We have a track record of bringing innovations to the market quickly, efficiently and economically with the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. Our end-to-end services make a compelling value proposition to our global innovator customers.

Enzo Life Sciences, Inc., a wholly owned subsidiary of Enzo Biochem, Inc. headquartered in Farmingdale, New York, is a recognised leader in labelling and detection technologies from DNA to whole cell across research and diagnostic markets. The company is organised to lead in the development, production, marketing, and sales of innovative research tools worldwide based on over 40 years of successful experience in building strong global market recognition, implementing outstanding operational capabilities and establishing a state-of-the-art electronic information and ordering marketplace.. . With a strong portfolio of proteins, antibodies, peptides, small molecules, labelling probes, dyes and kits, this provides researchers tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. To serve customers worldwide, Enzo Life Sciences has subsidiaries in UK, Germany, and Switzerland, France and Benelux and a network of partner companies allowing it to distribute products globally to over 50 additional countries.

UK based biotech specialising in diagnostics and therapeutics for use across brain cancers that are currently difficult to treat.